Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...
FOX 5 New York on MSN1d
Bronx open-air drug market continues to plague residents despite cleanup effortsAn open-air drug market at 149th Street and Melrose Avenue in the Bronx continues to thrive, despite city efforts to address ...
A review of the FDA’s drug approvals of 2024 shows that small companies loomed large—both in the sheer number of nods g | ...
Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.
Intra-Cellular Therapies stock leapt more than 30% Monday morning, after Johnson & Johnson agreed to buy the ...
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
A Virginia House committee on Tuesday advanced a bipartisan proposal to create a Prescription Drug Affordability Board, ...
Eli Lilly cut its outlook for fourth-quarter revenue citing sluggish growth in the market for incretin, which increases ...
Madrigal Pharmaceuticals' strong launch is confirmed with impressive sales in Q1 and Q2. Learn why MDGL stock could benefit ...
The key Ulcerative Colitis therapies expected to launch in the market include Jyseleca (filgotinib), Rinvoq (Upadacitinib), ...
January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback